Advertisement
Penumbra, Inc.

Penumbra, Inc. (PEN) Stock Overview

Explore Penumbra, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PENNYSE
HealthcareMedical - Devices
$318.58
$1.49(0.47%)
U.S. Market is Open · 15:00
Advertisement

Penumbra, Inc. (PEN)

Meyka AI Score

Z

Key Financials

Market Cap12.6B
P/E Ratio73.33
EPS (TTM)$4.33
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

PEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Penumbra, Inc. (PEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.40, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 73.33 and a market capitalization of 12.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.54%
5-Day Change
-0.76%
1-Month Change
-0.90%
3-Month Change
-5.17%
6-Month Change
5.37%
Year-to-Date (YTD) Change
2.71%
1-Year Change
24.87%
3-Year Change
-2.68%
5-Year Change
11.58%
All-Time (Max) Change
673.22%

Contact Information

510 748 3200
One Penumbra Place, Alameda, CA, 94502

Company Facts

45,000 Employees
IPO DateSep 18, 2015
CountryUS
Actively Trading

Frequently Asked Questions